
---
title: '半年报前瞻！药企业绩增速创新高，医疗器械成_排头兵_，千亿CRO巨头遭公募减仓，低估值且外资加仓的绩优股抢先看'
categories: 
 - 金融
 - 证券时报网
 - 数据
headimg: 'https://data.stcn.com/djsj/202207/W020220729270163428232.png'
author: 证券时报网
comments: false
date: Fri, 29 Jul 2022 07:29:00 GMT
thumbnail: 'https://data.stcn.com/djsj/202207/W020220729270163428232.png'
---

<div>   
<p>近期，医药行业上市公司已进入半年度业绩的披露高峰期。</p><p>证券时报·数据宝统计，截至7月28日，已发布半年报业绩（含预告/业绩快报）的医药公司有127家。</p><p><strong>五成以上医药公司业绩增长</strong></p><p>整体来看，这127家公司上半年录得净利润554.21亿元（预告按照预告中值计算，下同），实现扣非净利润379.91亿元，两者均创下2015年以来同期最高水平（以可比数据计算）。</p><p>127家医药公司上半年净利润整体同比增长67.23%，扣非净利润整体同比增长78.06%，两者依然创下近七年以来同期最高水平。自2020年以来，医药行业业绩已连续三年增长。</p><p style="text-align:center"><img class="rich_pages wxw-img" data-ratio="0.4527778" src="https://data.stcn.com/djsj/202207/W020220729270163428232.png" data-type="png" data-w="1080" data-imgqrcoded="1" style="margin: 0px; padding: 0px; max-width: 100%; vertical-align: middle; width: 500px; box-sizing: border-box; height: 226.389px; overflow-wrap: break-word !important;" width="500px" height="226.38888888888889px" oldsrc="W020220729270163428232.png" referrerpolicy="no-referrer"></p><p>从细分板块看，医疗服务、医疗器械板块上半年净利润同比翻倍，其中医疗器械公司实现净利润接近300亿元，同比增长142.55%。</p><p style="text-align:center"><img class="rich_pages wxw-img" data-ratio="0.5037037" src="https://data.stcn.com/djsj/202207/W020220729270164421683.png" data-type="png" data-w="1080" data-imgqrcoded="1" style="margin: 0px; padding: 0px; max-width: 100%; vertical-align: middle; width: 500px; box-sizing: border-box; height: 251.852px; overflow-wrap: break-word !important;" width="500px" height="251.85185185185182px" oldsrc="W020220729270164421683.png" referrerpolicy="no-referrer"></p><p><a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ002432" code="002432">九安医疗</a>净利润位居首位，公司上半年业绩爆发，净利润（中值）达到153亿元，位居首位，比上市以来的全部净利润还高（截至2021年），同比增幅超过270倍，业绩大增主要系美国疫情形势严峻，当地对新冠抗原检测试剂盒产品需求大幅增长。</p><p>净利润居次位的是CRO龙头<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SS603259" code="603259">药明康德</a>，上半年净利润46.36亿元，超过去2年同期总和，同比增长73.29%；另外，<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ002030" code="002030">达安基因</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SS603392" code="603392">万泰生物</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ002932" code="002932">明德生物</a>等上半年净利润均超过20亿元。</p><p>从增幅来看，五成以上医药公司业绩增长，28家公司净利润增幅超过100%。<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ002432" code="002432">九安医疗</a>净利润增幅仍位居首位；其次是<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SS688575" code="688575">亚辉龙</a>，超过650%，公司涉及新冠检测、肝炎等概念；<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SS600673" code="600673">东阳光</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ002102" code="002102">ST冠福</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ300534" code="300534">陇神戎发</a>等11家公司净利润增幅超过200%。</p><p>上半年仍有部分公司业绩表现不佳，比如<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ002044" code="002044">美年健康</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ000516" code="000516">国际医学</a>，自2020年以来，已连续3年半年报业绩亏损。<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ002044" code="002044">美年健康</a>表示，由于国内持续散点爆发的疫情，导致到检人数下降，公司上半年有150余家体检中心停业超40天。</p><p style="text-align:center"><img class="rich_pages wxw-img" data-ratio="0.5611111" src="https://data.stcn.com/djsj/202207/W020220729270164749309.png" data-type="png" data-w="1080" data-imgqrcoded="1" style="margin: 0px; padding: 0px; max-width: 100%; vertical-align: middle; width: 500px; box-sizing: border-box; height: 280.556px; overflow-wrap: break-word !important;" width="500px" height="280.55555555555554px" oldsrc="W020220729270164749309.png" referrerpolicy="no-referrer"></p><p><strong>资金布局医药股</strong></p><p>上半年医药股市场表现整体不佳，但仍获得各类资金布局。</p><p>数据宝统计，从基金持股情况看，与一季末相比，持股基金数上升的医药股（重仓股，以基金公布的数据为统计口径）数量略低于下降的公司，<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ300015" code="300015">爱尔眼科</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ300122" code="300122">智飞生物</a>新增200余家基金持股，<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ300595" code="300595">欧普康视</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SS600763" code="600763">通策医疗</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ300759" code="300759">康龙化成</a>等新增100家以上基金持股。</p><p>从持股比例变动来看，<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ301122" code="301122">采纳股份</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SS600085" code="600085">同仁堂</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ000999" code="000999">华润三九</a>等获基金加仓，其中<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ301122" code="301122">采纳股份</a>为年内上市新股，涉及辅助生殖、医疗器械等概念。已发布半年报公司中，<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SS688513" code="688513">苑东生物</a>获公募基金加仓，<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SS603259" code="603259">药明康德</a>等遭减仓。</p><p>从北上资金加仓情况看，年内获得北上资金加仓、最新市盈率低于行业平均水平（25倍）、半年报净利润增幅超过20%的医药股有7只。</p><p><a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ000915" code="000915">华特达因</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SS603387" code="603387">基蛋生物</a>获北上资金加仓幅度居前，前者加仓超过2个百分点。这7股年内平均上涨2.2%，<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ000915" code="000915">华特达因</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ002932" code="002932">明德生物</a>涨幅超过40%，<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ300841" code="300841">康华生物</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SS600518" code="600518">ST康美</a>跌幅超过25%。（数据宝 张娟娟）</p><p style="text-align:center"><img class="rich_pages wxw-img" data-cropselx1="0" data-cropselx2="562" data-cropsely1="0" data-cropsely2="403" data-ratio="0.6806569343065694" src="https://data.stcn.com/djsj/202207/W020220729270164993241.png" data-type="png" data-w="1096" data-imgqrcoded="1" style="margin: 0px; padding: 0px; max-width: 100%; height: 340.278px; vertical-align: middle; width: 500px; box-sizing: border-box; overflow-wrap: break-word !important;" width="500px" height="340.27777777777777px" oldsrc="W020220729270164993241.png" referrerpolicy="no-referrer"></p><p>声明：数据宝所有资讯内容不构成投资建议，股市有风险，投资需谨慎。</p>
  
</div>
            